CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $242 | +98.4% | 6,310 | +19.7% | 0.00% | +100.0% |
| Q1 2023 | $122 | -29.5% | 5,272 | -20.1% | 0.00% | -50.0% |
| Q4 2022 | $173 | -99.9% | 6,600 | +2.5% | 0.00% | +100.0% |
| Q3 2022 | $127,000 | +30.9% | 6,442 | +16.1% | 0.00% | 0.0% |
| Q2 2022 | $97,000 | +26.0% | 5,550 | +18.0% | 0.00% | 0.0% |
| Q1 2022 | $77,000 | – | 4,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |